摘要
目的观察莫西沙星治疗社区获得性肺炎的临床疗效及安全性。方法将108例轻申度社区获得性肺炎患者随机分成治疗组58例和对照组52例，两组分别给予莫西沙星口服和左氧氟沙星静脉点滴治疗。结果莫西沙星组较左氧氟沙星组无论在总有效率还是痊愈率以及安全性方面均有显著优势。结论莫西沙星治疗轻中度社区获得性肺炎的临床疗效确切，安全性高。
Objective To observe the clinical efficacy and safety of moxifloxacin for community-acquired pneumonia. Methods one hundred and eight cases of mild or moderate community-acquired pneumonia were randomly divided into treatment group （58 cases） and control group （52 cases）, the treatment group gave moxifloxacin and levofloxacin for control group. Results Efficiency or the cure rate and secure aspects in moxifloxacin group were is effective and safe advantage of those in levofloxacin group. Conclusion moxifloxacin for mild or moderate community-acquired pneumonia.
出处
《实用心脑肺血管病杂志》
2008年第4期302-304,共3页
Practical Journal of Cardiac Cerebral Pneumal and Vascular Disease
